$0.754
+0.003 (+0.44%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
TCRX 相似图表分析预测
Alphio's TCRX stock price prediction model matches the current TScan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.74 (-1.51%). The 1-week path is $0.73 (-3.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 TScan Therapeutics Inc 股票吗？
TScan Therapeutics Inc (TCRX) is currently trading at $0.75, which is significantly lower than the analyst price target of $5, indicating potential upside. However, the stock has a low Relative Strength Index (RSI) of 38.43, suggesting it is nearing oversold conditions, but it has also seen a 56.94% decline over the past year, indicating ongoing challenges. The company reported a Q2 2026 revenue of $1.1 million, down from $3.1 million in Q2 2025, reflecting weak market demand. The main risk is the negative net income of -$30.36 million in Q2 2026, which highlights profitability concerns.
TCRX 股价于 Friday 收于 $0.75，此前上涨 +0.44%
TScan Therapeutics Inc (TCRX) last closed at $0.7535, gaining +0.44%. These facts feed the 1-day and 1-week TCRX price prediction above.
预测驱动因素
TScan Therapeutics Inc（TCRX）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 TCRX 最接近的股票，按相似度排序。
TCRX 季节性分析
Historically the probability of a positive August return for TCRX is 20.63%. April offers the highest probability of a positive month at 64.06%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
TCRX 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Aug 2026 | $1.39 | $1.49 | $1.73 | +97.42% |
| Sep 2026 | $0.94 | $1.46 | $1.61 | +93.95% |
| Oct 2026 | $1.26 | $1.77 | $2.18 | +135.05% |
| Nov 2026 | $1.76 | $2.10 | $2.47 | +178.41% |
| Dec 2026 | $1.62 | $2.10 | $2.70 | +178.41% |
2026 年，TScan Therapeutics Inc（TCRX）预计区间为 $0.94 至 $2.70。
TScan Therapeutics Inc 2026 年月度预测
2026 年 Aug，TScan Therapeutics Inc 预计均价 $1.49，最低 $1.39，最高 $1.73。
2026 年 Sep，TScan Therapeutics Inc 预计均价 $1.46，最低 $0.94，最高 $1.61。
2026 年 Oct，TScan Therapeutics Inc 预计均价 $1.77，最低 $1.26，最高 $2.18。
2026 年 Nov，TScan Therapeutics Inc 预计均价 $2.10，最低 $1.76，最高 $2.47。
2026 年 Dec，TScan Therapeutics Inc 预计均价 $2.10，最低 $1.62，最高 $2.70。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。